<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
  <url>
    <loc>https://www.mdcecro.com</loc>
    <lastmod>2026-07-03T16:38:00.214Z</lastmod>
  </url>
  <url>
    <loc>https://www.mdcecro.com/about</loc>
    <lastmod>2026-07-03T16:38:00.214Z</lastmod>
  </url>
  <url>
    <loc>https://www.mdcecro.com/solution-area</loc>
    <lastmod>2026-07-03T16:38:00.214Z</lastmod>
  </url>
  <url>
    <loc>https://www.mdcecro.com/solution-area/mrct</loc>
    <lastmod>2026-07-03T16:38:00.214Z</lastmod>
  </url>
  <url>
    <loc>https://www.mdcecro.com/solution-area/fih</loc>
    <lastmod>2026-07-03T16:38:00.214Z</lastmod>
  </url>
  <url>
    <loc>https://www.mdcecro.com/solution-area/pmcf</loc>
    <lastmod>2026-07-03T16:38:00.214Z</lastmod>
  </url>
  <url>
    <loc>https://www.mdcecro.com/solution-area/bdd</loc>
    <lastmod>2026-07-03T16:38:00.214Z</lastmod>
  </url>
  <url>
    <loc>https://www.mdcecro.com/regulatory-affairs</loc>
    <lastmod>2026-07-03T16:38:00.214Z</lastmod>
  </url>
  <url>
    <loc>https://www.mdcecro.com/ai-product</loc>
    <lastmod>2026-07-03T16:38:00.214Z</lastmod>
  </url>
  <url>
    <loc>https://www.mdcecro.com/news</loc>
    <lastmod>2026-07-03T16:38:00.214Z</lastmod>
  </url>
  <url>
    <loc>https://www.mdcecro.com/contact</loc>
    <lastmod>2026-07-03T16:38:00.214Z</lastmod>
  </url>
  <url>
    <loc>https://www.mdcecro.com/contact/inquiry</loc>
    <lastmod>2026-07-03T16:38:00.214Z</lastmod>
  </url>
  <url>
    <loc>https://www.mdcecro.com/contact/career</loc>
    <lastmod>2026-07-03T16:38:00.214Z</lastmod>
  </url>
  <url>
    <loc>https://www.mdcecro.com/news/2025-overview-of-new-drug-registration-clinical-trials-in-china-structural-shifts-key-fields-and-rd-trends</loc>
    <lastmod>2026-07-03T05:28:48.929Z</lastmod>
  </url>
  <url>
    <loc>https://www.mdcecro.com/news/mdce-cro-achieves-a-100-success-rate-in-helping-two-chinese-companies-join-the-first-ema-breakthrough-medical-devices-btx-selections</loc>
    <lastmod>2026-06-22T09:59:40.493Z</lastmod>
  </url>
  <url>
    <loc>https://www.mdcecro.com/news/first-china-developed-neurointerventional-510k-cleared-with-mdce-cro-support-for-peijia-medical-after-fda-tightening</loc>
    <lastmod>2026-06-23T05:35:53.094Z</lastmod>
  </url>
  <url>
    <loc>https://www.mdcecro.com/news/deepening-our-presence-in-brazil-mdce-cro-holds-another-in-depth-dialogue-with-strategic-partner-synvia</loc>
    <lastmod>2026-06-23T05:47:00.935Z</lastmod>
  </url>
  <url>
    <loc>https://www.mdcecro.com/news/mdce-helps-fourth-chinese-medtech-company-obtain-fda-breakthrough-device-designation-1</loc>
    <lastmod>2026-06-03T03:41:49.516Z</lastmod>
  </url>
  <url>
    <loc>https://www.mdcecro.com/news/key-changes-to-eu-mdr-post-market-surveillance-requirements-what-medtech-companies-need-to-know-3</loc>
    <lastmod>2026-06-03T03:41:49.517Z</lastmod>
  </url>
  <url>
    <loc>https://www.mdcecro.com/news/first-in-class-dermatology-phase-ii-clinical-trial-initiated-in-australia</loc>
    <lastmod>2026-06-03T03:41:49.519Z</lastmod>
  </url>
  <url>
    <loc>https://www.mdcecro.com/news/mdce-cro-secures-singapore-irb-approval-for-medtech-partner</loc>
    <lastmod>2026-06-23T05:48:48.984Z</lastmod>
  </url>
  <url>
    <loc>https://www.mdcecro.com/news/mdce-cro-secures-multiple-fda-breakthrough-device-designations</loc>
    <lastmod>2026-06-23T05:49:31.748Z</lastmod>
  </url>
  <url>
    <loc>https://www.mdcecro.com/news/mdce-secures-fda-breakthrough-for-innovative-bone-screws</loc>
    <lastmod>2026-06-23T05:50:00.825Z</lastmod>
  </url>
  <url>
    <loc>https://www.mdcecro.com/news/mdce-cro-achieves-successful-database-lock-for-high-risk-eu-pmcf-study</loc>
    <lastmod>2026-06-23T05:49:50.262Z</lastmod>
  </url>
</urlset>